Biogen Inc. (BIIB)

Sector:Health Care
Super Investor Stats:
Ownership count:2
Ownership rank:373
% of all portfolios:0.027%
Hold Price * :$215.81
History Portfolio Manager Activity Share change % change to portfolio
Q1  2024
Hillman Value Fund Add 0.57% 139 0.01
Q4  2023
Lee Ainslie - Maverick Capital Buy 1,600 0.01
Q3  2023
Hillman Value Fund Add 32.86% 6,000 0.76
Q2  2023
Lee Ainslie - Maverick Capital Buy 983 0.01
Q1  2022
Hillman Value Fund Add 59.89% 10,900 0.97
Q4  2021
Mason Hawkins - Longleaf Partners Buy 337,077 4.86
Q3  2021
Lee Ainslie - Maverick Capital Buy 3,112 0.01
Q2  2021
Bill Miller - Miller Value Partners Buy 79,493 0.72
Q1  2021
Hillman Value Fund Add 37.88% 5,000 0.83
Mason Hawkins - Longleaf Partners Buy 249,422 4.59
Q3  2020
Hillman Value Fund Add 32.00% 3,200 0.92
Q2  2020
First Eagle Investment Management Buy 57,300 0.05
Lee Ainslie - Maverick Capital Buy 4,501 0.03
Q4  2019
Hillman Value Fund Add 25.00% 2,000 0.67
Warren Buffett - Berkshire Hathaway Buy 648,447 0.08
Q3  2019
Hillman Value Fund Add 33.33% 2,000 0.77
Lee Ainslie - Maverick Capital Buy 4,919 0.02
Q2  2019
Hillman Value Fund Add 20.00% 1,000 0.54
Q1  2019
Hillman Value Fund Buy 5,000 3.83
Q2  2017
Lee Ainslie - Maverick Capital Add 58.48% 5,620 0.02
Q4  2016
Lee Ainslie - Maverick Capital Add 4.82% 500 0.00
Q2  2016
Lee Ainslie - Maverick Capital Add 17.50% 1,640 0.01
Q1  2016
Lee Ainslie - Maverick Capital Buy 9,370 0.04

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.